Penetrium Bioscience Inc. (KOSDAQ:187660)
South Korea · Delayed Price · Currency is KRW 5,770.00
+140.00 (2.49%)
At close: Oct 23, 2026
Penetrium Bioscience Market Cap
Penetrium Bioscience has a market cap or net worth of 315.98 billion as of October 23, 2026. It is the 19,580th most valuable company in the world and the 603rd biggest in South Korea. Its market cap has increased by 94.41% in one year.
Market Cap
315.98B
Enterprise Value
n/a
Revenue
9.74B
Global Rank
Country Rank
#603 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since June 3, 2021, Penetrium Bioscience's market cap has increased from 215.74B to 315.98B, an increase of 46.46%. That is a compound annual growth rate of 7.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 315.98B | 142.44% |
| Dec 30, 2025 | 130.34B | 86.73% |
| Dec 30, 2024 | 69.80B | 57.99% |
| Dec 28, 2023 | 44.18B | 1.39% |
| Dec 29, 2022 | 43.58B | -66.41% |
| Dec 30, 2021 | 129.71B | -39.88% |
| Jun 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ingenia Therapeutics | 1.07T |
| HLB bioStep | 112.35B |
| DreamCIS | 102.46B |
| P&K Skin Research Center | 49.10B |
| Kolmar BioTech | 34.84B |
| DT&CRO CO. | 27.42B |
| SLS BIO | 26.89B |
| C&R Research | 25.80B |